Latest News

October 14, 2002
Both drugs and psychological intervention alone or together can help smokers stay away from cigarettes for the short term but not long term, according to a study on smoking cessation at the University of California, San Francisco. This was the first smoking cessation study that compared nortriptyline, a drug used to treat depression, and a drug that has FDA approval for smoking cessation treatment—- sustained release bupropion—-as well as psychological intervention.
October 10, 2002
The UCSF Center for the Health Professions will celebrate its ten-year anniversary on October 14, 2002 with a day-long symposium. * WHAT: UCSF Center for Health Professions 10 -year Anniversary Symposium * WHERE: Laurel Heights Conference Center, 3333 California, SF * TIME: October 14, 2002, 9a.m. to 5p.m.  Reception to follow.
October 09, 2002
One of the most commonly broken New Year’s resolutions is to quit smoking cigarettes.  A study beginning this month at San Francisco Veterans Affairs Medical Center will test whether hypnosis can help smokers fight off their cigarette cravings. “Smokers in this study will learn how to use self-hypnosis skills to strengthen their resolve, particularly at the moment of a craving,” said researcher Tim Carmody, PhD, director of health psychology at SFVAMC and UCSF clinical professor of psychiatry.
October 07, 2002
## 15 Seconds: San Francisco General Hospital Medical Center will conduct a clinical trial this fall intended to help patients suffering severe brain damage as a result of accidents or assaults.  The study will involve lowering patien’s body temperature.  For more information, call 415/206-3220. ## 20 Seconds:
October 07, 2002
Neurocirujanos de la Universidad de California en San Francisco están planeando realizar un estudio en el Hospital General de esta ciudad para determinar si bajar la temperatura del cuerpo de los pacientes con lesiones traumáticas del cerebro es eficaz para mejorar el estado de salud de estas personas. 
October 07, 2002
UCSF neurosurgeons at San Francisco General Hospital Medical Center are planning a unique clinical study to see if lowering the body temperature of patients with severe traumatic brain injury (TBI) will help improve their condition - but first the neurosurgeons need to reach the local public, in part through the media.
October 02, 2002
The trouble with most anti-anxiety drugs is that they tend to sedate, not just relax. A research team led by scientists at UCSF’s Ernest Gallo Clinic and Research Center has shown that de-activating a common enzyme in neurons reduces anxiety without inducing sedation. The study in mice suggests a new route to treat anxiety while avoiding sedating and possibly addicting effects. The research, published in the October issue of The Journal of Clinical Investigation, also showed that blocking the enzyme reduced levels of stress hormones.
September 30, 2002
UCSF researchers have found that macrophages-literally “big eaters,” normally key immune defense cells that engulf and devour bacteria and tumor cells-when taken from HIV-infected lymphoma patients and injected into mice, induced aggressive mouse T-cell lymphomas in the mice.  Macrophages from healthy donors did not.
September 30, 2002
Maurice Sokolow, MD, a cardiologist and an international expert in hypertension, died Thursday of cancer at UCSF Medical Center in San Francisco.  He was 91 years old. “Sokolow was a pioneer in the field of hypertension, including the effects of stress on blood pressure,” said Lee Goldman, MD, MPH, UCSF chair of the department of medicine and professor of medicine, “and he was a beloved member of the UCSF community since 1936.”
September 30, 2002
With the help of data from the Human Genome Project, UCSF scientists have developed a new technique for screening tumors that highlights the role of a non-genetic mechanism in cancer. The researchers say the approach, which they applied to the study of human brain tumors, “widens the lens” on the cancer genome, and could lead to new therapeutic targets.

Pages